| http://www.w3.org/ns/prov#value | - But results from JASAP (Japanese Aggrenox Stroke Prevention vs. Aspirin Programme), which compared Aggrenox to aspirin in 1294 patients, found that Aggrenox failed to cause a significant reduction in recurrent stroke, and in fact there was a trend toward more strokes in the Aggrenox group than in the aspirin group (45 versus 32, p=0.097).
|
